Executed global exclusive development and commercialization license agreement with Novartis to advance VAV1-directed molecular glue degraders including MRT-6160 for immune-related conditions; $150M ...
Gilead Sciences, Inc. (Nasdaq: GILD) announced today its third quarter 2024 results of operations. “Gilead’s third quarter results are the strongest o ...
Since the 2022 year opening price of $78.09 per barrel, today’s Brent crude oil price is down 3.84%. WTI crude oil is up 0.46% compared to it’s previous trading day. WTI crude oil also opened 2021 ...
ONSHINDO OSAKA, the first Japanese cosmetics line to be sold in pharmacies, presents its innovative double-use face mask, UMINOIRO, designed to transform and revitalise the skin. It offers an ...
Positive Interim Analysis of Phase 3 ENSURE Program, Unblinded Independent Data Monitoring Committee Confirmed that Predetermined Futility Criteria Have Not Been Met and Recommended Trials Should ...